May 29, 2024
trypsin Market

Trypsin Market is poised to grow in medical research by increased funding

The trypsin market is involved in the manufacturing and commercialization of trypsin enzyme extracted from various sources including bovine and porcine pancreas. Trypsin finds wide applications in several industries such as medical research, food processing, personal care, leather processing and more. It acts as an excellent protease for bacterial cell wall digestion and is commonly used in cell dissociation and detachment processes during routine passaging of mammalian cells in research and bioprocessing. The trypsin enzyme cleaves peptide bonds at the carboxyl end of arginine and lysine amino acid residues making it widely applicable in medical research for protein sequencing, digestion of proteins, mapping protein structures and functions.

The Global Trypsin Market is estimated to be valued at US$ 53.83 Bn in 2024 and is expected to exhibit a CAGR of 8.6% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Trypsin Market Size are Pfizer, Inc., GlaxoSmithKline plc, Johnson & Johnson Services Inc., Merck & Company, Inc., Novartis AG, Amgen, Inc., AstraZeneca plc, Eli Lily and Company, AbbVie Inc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Biogen Inc., Sun Pharmaceutical Industries Ltd, Mylan, Inc., Aurobindo Pharma Limited, and Dr. Reddy€TMs Laboratories.

The growing demand for trypsin enzyme in biopharmaceutical and medical research is one of the major factors augmenting the market growth. Trypsin is widely used as an important protease in the development and manufacturing of therapeutic proteins and vaccines. Furthermore, with the increased governmental and private funding for medical research activities, the demand for trypsin is expected to rise significantly over the forecast period.

Globally, North America dominates the trypsin market and is expected to continue its dominance during the forecast period. This is attributed to the strong presence of major biopharmaceutical companies and rising research expenditure in the region. However, Asia Pacific trypsin market is anticipated to exhibit fastest growth rate owing to growing biologics outsourcing, increasing number of CROs and rapid economic development in countries like China and India.

Market key trends

The key trend gaining foothold in the Trypsin Market Size is the development of recombinant or genetically engineered trypsin enzymes. Traditional trypsin extraction process involves use of animal sources like bovine and porcine pancreas. However, rising concerns over transmission of animal diseases and stringent regulations have prompted companies to focus on production of recombinant trypsin using microbial fermentation. Recombinant trypsin offers advantages such as consistent quality, unlimited supply and freedom from transmission of infectious agents. Major players are investing in R&D activities to develop proprietary technologies for large-scale production of recombinant trypsin.

Porter’s Analysis

Threat of new entrants: The threat of new entrants is moderate as the biotech industry requires large investments in R&D and time to develop new drugs. However, small biotech companies can enter the market with novel drugs.

Bargaining power of buyers: The bargaining power of buyers is high as the market is fragmented with many global pharmaceutical manufacturers. Buyers can negotiate on price points.

Bargaining power of suppliers: The bargaining power of suppliers is moderate as key raw materials are commoditized but suppliers have differentiated products. This gives them some control over prices.

Threat of new substitutes: The threat of new substitutes is low as there are limited therapeutic alternatives for many disease treatments. Brand loyalty is also high.

Competitive rivalry: The competitive rivalry is high due to many global brand leaders competing for market share.

Geographical Regions

North America dominates the trypsin market in terms of value owing to developed healthcare infrastructure and higher diagnosis rates. Rising incidence of pancreatic diseases is also propelling the regional market.

Asia Pacific is poised to be the fastest growing region for the trypsin market during the forecast period. This is attributed to growing medical tourists, increasing healthcare spending, and expansion of key players seeking low-cost manufacturing opportunities.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it